SEC Comment Letter for 1Life Healthcare Inc (CIK 0001404123) — Jul 9, 2021
1Life Healthcare Inc (CIK 0001404123)
Date: July 9, 2021 · CIK: 0001404123 · Accession: 0000000000-21-008507
AI Filing Summary & Sentiment
File numbers found in text: 333-257720
Letter
United States securities and exchange commission logo July 9, 2021 Amir Dan Rubin Chair, Chief Executive Officer and President 1Life Healthcare Inc One Embarcadero Center, Suite 1900 San Francisco, CA 94111 Re:1Life Healthcare Inc Registration Statement on Form S-4 Filed July 6, 2021 File No. 333-257720 Dear Mr. Rubin: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Schwartz at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Steven J. Tonsfeldt, Esq.
Show Raw Text
United States securities and exchange commission logo
July 9, 2021
Amir Dan Rubin
Chair, Chief Executive Officer and President
1Life Healthcare Inc
One Embarcadero Center, Suite 1900
San Francisco, CA 94111
Re:1Life Healthcare Inc
Registration Statement on Form S-4
Filed July 6, 2021
File No. 333-257720
Dear Mr. Rubin:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Schwartz at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Steven J. Tonsfeldt, Esq.